Epilepsy Development Articles & Analysis
6 news found
KT Corporation and NeuroSigma, Inc. jointly announced signing of a memorandum of understanding, forming a strategic partnership to develop and commercialize, inside and outside of Korea, electronic therapies treating neurological and neuropsychological disorders, including ADHD, depression, and epilepsy. NeuroSigma is the developer of the Monarch ...
The prevalence of sleep disorders, epilepsy and cardiovascular disease pose a significant challenge to the US healthcare system. Notably, 70 million Americans suffer from some form of a sleep disorder, 1 in 26 people will develop epilepsy or recurrent seizures during their lifetime, and 48% of all adults in the US have some type of cardiovascular ...
“The goal of our research grants program is to accelerate the development of new therapies and diagnostic devices so that we can get them to people with epilepsy faster, and in a time frame that matters,” says Sonya Dumanis, PhD senior director of Innovation, Epilepsy Foundation. ...
It is estimated that 1 in 100 people have epilepsy, and 1 in 3 people with epilepsy continue to experience uncontrollable and unpredictable seizures despite medication. ...
Brain Sentinel Consumer Systems, LLC (herein “Brain Sentinel”) announces the global launch of its new SeizureLink™ Alerting System at the Epilepsy Foundation’s “2018 Epilepsy Pipeline Conference”, currently being held in San Francisco, CA. ...
"From life-saving technology to incredible space engineering to gadgets that are just breath-takingly cool, this is the best of what’s new.” Epilepsy affects over 3.4M people in the US and 65M people worldwide. One in twenty six Americans will develop epilepsy in their lifetime, according to the CDC. ...